This inventor holds 1 USPTO granted patent. Top assignees: George Mason University, St. Jude Children's Research Hospital, The George Washington University. Active years: 2017.
Company Filing History:
1 out of 270 
1 out of 281 
1 out of 282 
Years Active: 2017
Title: Emily R. Jackson: Innovator in Biochemical Compounds
Introduction
Emily R. Jackson is a notable inventor based in Springfield, VA (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit specific enzymes. Her work has implications for various medical applications, showcasing her innovative spirit and dedication to scientific advancement.
Latest Patents
Emily R. Jackson holds a patent for "Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase." This invention is particularly effective in inhibiting Dxr in Mycobacterium tuberculosis (Mtb). The compounds she developed are represented by general formulas (I) or (II), highlighting her expertise in creating effective biochemical solutions. She has 1 patent to her name.
Career Highlights
Throughout her career, Emily has worked with prestigious institutions, including Washington University and George Mason University. Her roles in these organizations have allowed her to collaborate with leading researchers and contribute to groundbreaking studies in her field.
Collaborations
Emily has collaborated with esteemed colleagues, including Helena I. Boshoff and Cynthia Dowd. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Emily R. Jackson is a pioneering inventor whose work in biochemical compounds demonstrates her commitment to innovation and scientific progress. Her contributions are vital to the ongoing research in the field, and her patent reflects her significant role in advancing medical science.